• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA甲基转移酶1、3a和3b在光化性唇炎和唇部鳞状细胞癌中的免疫组织化学表达

Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas.

作者信息

Daniel Filipe I, Alves Soraia R, Vieira Daniella S C, Biz Michelle T, Daniel Inah W B S, Modolo Filipe

机构信息

Pathology Department and Dentistry Graduate Program, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.

Private Dentist, Florianopolis, Santa Catarina, Brazil.

出版信息

J Oral Pathol Med. 2016 Nov;45(10):774-779. doi: 10.1111/jop.12453. Epub 2016 May 9.

DOI:10.1111/jop.12453
PMID:27159259
Abstract

BACKGROUND

Epigenetic modifications, including DNA methylation of tumor suppressor genes carried out by DNA methyltransferases (DNMTs), are important events in carcinogenesis. Although there are studies concerning to its expression in several cancer types, DNMTs expression pattern is not known in photoinduced lip carcinogenesis. The aim of this study was to investigate the immunoexpression of DNMTs 1, 3a, and 3b in lip precancerous lesion (actinic cheilitis) and cancer.

METHODS

Thirty cases of actinic cheilitis (AC), thirty cases of lip squamous cell carcinoma (LSCC), and twenty cases of non-neoplastic tissue (NNT) were selected for immunohistochemical investigation of DNMTs 1, 3a, and 3b.

RESULTS

Nuclear DNMT 1 immunoreactivity was significantly higher in the LSCC group (68.6%) compared with NNT (47%), and nuclear DNMT 3b was higher in LSCC (70.9%) than in NNT (37.9%) and in AC (44%). Only DNMT 3a showed both higher nuclear and cytoplasmic expression in AC (35.9% and 35.5%, respectively) than in NNT (4.4% and 16.1%, respectively) and LSCC (8.8% and 13.2%, respectively) (P < 0.05).

CONCLUSIONS

The results suggested that DNMT 3a could play a key role in the methylation process of initial steps of UV carcinogenesis present in AC while DNMT 3b could be responsible for de novo methylation in already established lip cancer.

摘要

背景

表观遗传修饰,包括由DNA甲基转移酶(DNMTs)进行的肿瘤抑制基因的DNA甲基化,是致癌过程中的重要事件。尽管有研究涉及其在几种癌症类型中的表达,但在光诱导性唇癌发生过程中DNMTs的表达模式尚不清楚。本研究的目的是调查DNMTs 1、3a和3b在唇部癌前病变(光化性唇炎)和癌症中的免疫表达情况。

方法

选取30例光化性唇炎(AC)、30例唇鳞状细胞癌(LSCC)和20例非肿瘤组织(NNT),对DNMTs 1、3a和3b进行免疫组织化学研究。

结果

与NNT组(47%)相比,LSCC组核DNMT 1免疫反应性显著更高(68.6%),且LSCC组核DNMT 3b(70.9%)高于NNT组(37.9%)和AC组(44%)。仅DNMT 3a在AC组中的核表达和胞质表达均高于NNT组(分别为35.9%和35.5%)和LSCC组(分别为8.8%和13.2%)(P < 0.05)。

结论

结果表明,DNMT 3a可能在AC中存在的紫外线致癌初始步骤的甲基化过程中起关键作用,而DNMT 3b可能负责已形成的唇癌中的从头甲基化。

相似文献

1
Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas.DNA甲基转移酶1、3a和3b在光化性唇炎和唇部鳞状细胞癌中的免疫组织化学表达
J Oral Pathol Med. 2016 Nov;45(10):774-779. doi: 10.1111/jop.12453. Epub 2016 May 9.
2
Immunoexpression of HDAC1, HDAC2, and HAT1 in actinic cheilitis and lip squamous cell carcinoma.HDAC1、HDAC2和HAT1在光化性唇炎和唇部鳞状细胞癌中的免疫表达
Oral Dis. 2017 May;23(4):505-510. doi: 10.1111/odi.12641. Epub 2017 Mar 9.
3
Immunohistochemical expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9, myofibroblasts and Ki-67 in actinic cheilitis and lip squamous cell carcinoma.基质金属蛋白酶-1、基质金属蛋白酶-2和基质金属蛋白酶-9、肌成纤维细胞及Ki-67在光化性唇炎和唇部鳞状细胞癌中的免疫组化表达
Int J Exp Pathol. 2015 Oct;96(5):311-8. doi: 10.1111/iep.12140. Epub 2015 Oct 30.
4
Correlation between cell cycle proteins and hMSH2 in actinic cheilitis and lip cancer.光化性唇炎和唇癌中细胞周期蛋白与hMSH2的相关性
Arch Dermatol Res. 2016 Apr;308(3):165-71. doi: 10.1007/s00403-016-1625-z. Epub 2016 Feb 3.
5
Immune response and evasion mechanisms in lip carcinogenesis: An immunohistochemical study.在唇癌发生中的免疫反应和逃逸机制:免疫组织化学研究。
Arch Oral Biol. 2019 Feb;98:99-107. doi: 10.1016/j.archoralbio.2018.09.017. Epub 2018 Sep 29.
6
Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.在光化性唇炎和唇癌中癌干细胞标志物 CD44、ALDH1 和 p75NTR 的表达。
Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1877-1883. doi: 10.1007/s00405-018-5002-8. Epub 2018 May 19.
7
Study of MDM2 and SUMO-1 expression in actinic cheilitis and lip cancer.光化性唇炎和唇癌中MDM2与SUMO-1表达的研究
Arch Dermatol Res. 2014 Nov;306(9):837-41. doi: 10.1007/s00403-014-1500-8. Epub 2014 Sep 21.
8
Decreased Nuclear Immunoexpression of ING3 is a Frequent Event in Lip Carcinogenesis.ING3 核免疫表达减少是唇癌发生的一个常见事件。
Head Neck Pathol. 2024 Oct 16;18(1):103. doi: 10.1007/s12105-024-01683-w.
9
Evaluation of specific modified histones in lip carcinogenesis.唇癌发生中特定修饰组蛋白的评估。
Pathol Res Pract. 2018 Jun;214(6):876-880. doi: 10.1016/j.prp.2018.04.004. Epub 2018 Apr 22.
10
Immunoexpression of glucocorticoid receptor alpha (GRα) isoform and apoptotic proteins (Bcl-2 and Bax) in actinic cheilitis and lower lip squamous cell carcinoma.糖皮质激素受体 α(GRα)异构体和凋亡蛋白(Bcl-2 和 Bax)在光化性唇炎和下唇鳞状细胞癌中的免疫表达。
J Oral Pathol Med. 2018 Sep;47(8):788-795. doi: 10.1111/jop.12757. Epub 2018 Jul 12.

引用本文的文献

1
Enhanced Transcriptional Signature and Expression of Histone-Modifying Enzymes in Salivary Gland Tumors.唾液腺肿瘤中组蛋白修饰酶的转录特征和表达增强。
Cells. 2023 Oct 11;12(20):2437. doi: 10.3390/cells12202437.
2
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.小分子谱分析定义头颈部鳞状细胞癌中协同的 EGFR 抑制剂组合。
Head Neck. 2022 May;44(5):1192-1205. doi: 10.1002/hed.27018. Epub 2022 Feb 27.
3
Expression of DNMTs and H3K9ac in Ameloblastoma and Ameloblastic Carcinoma.
成釉细胞瘤和成釉细胞癌中DNA甲基转移酶(DNMTs)和组蛋白H3赖氨酸9乙酰化(H3K9ac)的表达
Front Oral Health. 2021 Oct 26;2:751162. doi: 10.3389/froh.2021.751162. eCollection 2021.
4
A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGA.基于 TCGA 的中国肺腺癌预后功能性甲基化特征。
Cancer Med. 2022 Jan;11(1):281-294. doi: 10.1002/cam4.4431. Epub 2021 Dec 2.
5
Actinic cheilitis: proposition and reproducibility of a clinical criterion.光化性唇炎:一项临床标准的提出与可重复性
BDJ Open. 2017 Aug 4;3:17016. doi: 10.1038/bdjopen.2017.16. eCollection 2017.